Evidence map›Paper›PMID 39399675›Full record

ArticleResearch square2024

Catalyzing Change: Assessing Inner Setting Context of Cervical Cancer Prevention Efforts in Loreto, Peru, Prior to Transition from VIA to HPV Screen-and-Treat.

Lauren Nussbaum, Joanna Brown, Graciela Meza-Sánchez, Sandra Soto, Magdalena Jurczuk, Javier Vásquez Vásquez, Henrry Daza Grandez, Lita E Carrillo Jara, Renso López Liñán, Patti E Gravitt and 1 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Lauren NussbaumTulane University School of Public Health and Tropical Medicine.
Joanna BrownAsociación Benéfica PRISMA.
Graciela Meza-SánchezUniversidad Nacional de la Amazonía Peruana.
Sandra SotoAsociación Benéfica PRISMA.
Magdalena JurczukTulane University School of Public Health and Tropical Medicine.
Javier Vásquez VásquezUniversidad Nacional de la Amazonía Peruana.
Henrry Daza GrandezGerencia Regional de Salud.
Lita E Carrillo JaraGerencia Regional de Salud.
Renso López LiñánUniversidad Nacional de la Amazonía Peruana.
Patti E GravittNational Cancer Institute, National Institutes of Health.
Valerie A Paz-SoldánTulane University School of Public Health and Tropical Medicine.

Funding

Translating Molecular Diagnostics for Cervical Cancer Prevention into PracticeR01CA190366 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI PAZ-SOLDAN, VALERIE ANDREA, TRACY, J. KATHLEEN · 2016 to 2020
$2.7M
Translating Molecular Diagnostics for Cervical Cancer Prevention into PracticeU01CA190366 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PAZ-SOLDAN, VALERIE ANDREA, TRACY, J. KATHLEEN · 2021 to 2025
$2.1M
NCI NIH HHS R01 CA190366NCI NIH HHS U01 CA190366
6 · The paper itself

Abstract

Background: The objective of this study was to understand health care providers' perspectives regarding the facilitators of and barriers to the success of the former Pap and VIA-based cervical cancer program in Iquitos, Peru, using the Consolidated Framework for Implementation Research (CFIR) to inform the transition to the HPV screen-and-treat intervention. By exploring the pre-implementation organizational context, or inner setting, through the opinions of those who would implement the HPV-based intervention at the patient care level, this research lays the foundation to assess readiness before implementation and understand what's necessary to design contextually appropriate and sustainable interventions in LMIC settings. Methods: We conducted 19 semi-structured interviews with health professionals (12 nurse-midwives, 4 doctors, and 3 laboratory technicians) who administered the former Pap- and VIA-based cervical cancer EDT program. Results: Providers identified information gaps between the primary level of care, where cervical cancer screening occurs, and the hospital level of care, where diagnosis and treatment occurs. These gaps, which were caused in part by fragmented, antiquated, and overlapping data systems, resulted in the loss of patients between levels of care. Participants also noted a lack of trained personnel and basic materials. Some providers found their way around these gaps by facilitating informal information exchanges among providers to ensure women were not lost to follow-up. Conclusions: PPC relied on these findings and other data from INSPIRE Phase 1 to implement a HPV-based screen-and-treat program that dramatically increased screening and treatment; however, challenges remain regarding resources and sustainability related to HPV technology.

Indexed as

cervical cancerHPVInner settingPeru

Identifiers

PMID39399675
PMCPMC11469402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.